As shown in Figure 5I, compared with HER2+ and HR+ breast cancers, FOXA1 was lowly expressed in TBNC, while FOXC1, FOXK2, and FOXM1 were highly expressed. This evidence concerns the gene FOXK2 and breast cancer.